Hyalex Orthopaedics Increases Series A Total to $33MM
Hyalex Orthopaedics, developer of HYALEX synthetic polymer that is designed to mimic hyaline cartilage, grew its original Series A funding to US...
Mar 28, 2019,
Hyalex Orthopaedics Increases Series A Total to $33MM
SpineEX Issued New U.S. Patent
SpineEX was issued its second U.S. patent, addressing a novel mechanism to adjust posterior and anterior sides of an interbody...
Mar 28, 2019, Julie Vetalice
Bioventus Launches OSTEOAMP SELECT Fibers
Bioventus introduced OSTEOAMP® SELECT Fiber allograft bone graft substitute for spine, foot/ankle, orthopedic and trauma procedures....
Mar 27, 2019, Julie Vetalice
Exactech’s First Hip Procedure with Alteon Cup and XLE Liner
Exactech announced the successful first hip replacement with the Alteon® Cup and XLE® Liner....
Mar 27, 2019, Julie Vetalice
MiRus Gains FDA Clearance for Molybdenum Rhenium Pedicle Screw
MiRus received FDA 510(k) clearance for the Europa pedicle screw made of MoRe® molybdenum rhenium superalloy material....
Mar 27, 2019, Julie Vetalice
SpineEX Receives Additional FDA Clearance for Sagittae LLIF
SpineEX gained additional FDA clearance for the Sagittae Lateral Lumbar Interbody Fusion system, covering new instrumentation and an updated surgical technique....
Mar 26, 2019, Julie Vetalice
Bone Biologics Receives Approval for Trial of NB1 Growth Factor in Australia
Bone Biologics received regulatory approval in Australia for a multicenter pilot clinical trial to evaluate NELL-1/DBX® in the treatment of degenerative disc disease....
Mar 25, 2019, Julie Vetalice
Zimmer Biomet Gains FDA Clearance of ROSA ONE Spine System for Robotically-Assisted Surgeries
Zimmer Biomet received FDA 510(k) clearance to market the ROSA® ONE Spine System for robotically-assisted spine procedures....
Mar 25, 2019, Julie Vetalice
Seikagaku Launches HyLink in Italy
Seikagaku commenced Italy launch of HyLink® single-injection viscosupplement for knee osteoarthritis....
Mar 22, 2019, Julie Vetalice
Graftys Completes Capital Raise for Expansion
Graftys completed a ‚¬4.1MM (~US $4.6MM) funding round. Proceeds will support commercialization of QuickSet cement and HBS injectable calcium phosphate bone graft substitute....
Mar 22, 2019, Julie Vetalice
Loading new posts...
No more posts
